drugset / Trial / NCT00691717
Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular Hypertension
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study was to evaluate the safety and intraocular-lowering efficacy of anecortave acetate depot when administered by anterior juxtascleral depot (AJD) for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anecortave Acetate | Small molecule | 24 mg | Other |
| Subject | Anecortave Acetate | Small molecule | 48 mg | Other |
| Subject | Anecortave Acetate | Small molecule | 60 mg | Other |